MEI Pharma - 22 Year Stock Price History | MEIP

Historical daily share price chart and data for MEI Pharma since 2003 adjusted for splits and dividends. The latest closing stock price for MEI Pharma as of May 02, 2025 is 2.04.
  • The all-time high MEI Pharma stock closing price was 11903.50 on February 11, 2004.
  • The MEI Pharma 52-week high stock price is 4.10, which is 101% above the current share price.
  • The MEI Pharma 52-week low stock price is 1.46, which is 28.4% below the current share price.
  • The average MEI Pharma stock price for the last 52 weeks is 2.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MEI Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.4316 2.5500 2.8800 1.8600 2.0350 -17.28%
2024 3.3837 6.0100 6.0100 2.3600 2.4600 -57.59%
2023 5.0544 3.9305 6.7300 3.2625 5.8000 53.26%
2022 12.9367 42.5679 42.5679 3.3728 3.7845 -90.88%
2021 47.4807 43.0339 69.9107 36.1982 41.4804 1.14%
2020 42.5184 37.2857 66.8036 11.6192 41.0143 6.45%
2019 36.6874 40.8589 51.5786 22.9929 38.5286 -6.06%
2018 48.3399 34.0232 76.9018 29.3625 41.0143 25.71%
2017 33.1920 21.7500 47.8500 21.7500 32.6250 45.83%
2016 22.9605 25.9446 32.0036 15.6911 22.3714 -10.00%
2015 37.9232 67.2696 97.8750 23.1482 24.8571 -62.53%
2014 115.1138 122.5770 179.2820 58.8804 66.3375 -46.69%
2013 123.1519 111.0800 174.7770 73.0179 124.4410 14.43%
2012 72.0048 102.5360 199.4790 33.4546 108.7530 12.18%
2011 137.2683 93.2143 294.5570 85.7571 96.9429 7.22%
2010 272.9027 643.1790 745.7140 70.9361 90.4179 -86.14%
2009 601.4552 643.1790 978.7500 242.3570 652.5000 0.00%
2008 1912.6191 2712.5400 3261.0100 428.7860 652.5000 -75.78%
2007 3102.3329 2973.5400 4287.8600 2265.1100 2693.8900 -5.56%
2006 3853.2421 6413.1400 6646.1800 2582.0400 2852.3600 -51.04%
2005 6866.0271 8389.2900 8389.2900 5266.6100 5825.8900 -30.13%
2004 8722.7689 11465.4000 11903.5000 5574.2100 8338.0200 -24.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.014B $0.065B
MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $98.106B 36.80
Zoetis (ZTS) US $70.247B 26.59
Daiichi Sankyo, - (DSNKY) JP $49.445B 25.16
Takeda Pharmaceutical (TAK) JP $48.747B 10.79
Summit Therapeutics (SMMT) US $20.720B 0.00
Sandoz Group AG (SDZNY) CH $19.545B 0.00
Merck (MKKGY) DE $18.346B 15.18
Shionogi (SGIOY) JP $14.436B 14.46
United Therapeutics (UTHR) US $13.289B 11.76
Neurocrine Biosciences (NBIX) US $10.852B 33.34
IPSEN (IPSEY) FR $9.920B 0.00
Orion OYJ (ORINY) FI $8.948B 24.20
Corcept Therapeutics (CORT) US $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) US $7.005B 0.00
Stevanato Group S.p.A (STVN) IT $6.475B 41.12
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.217B 0.00
Grifols, S.A (GRFS) ES $5.054B 0.00
Soleno Therapeutics (SLNO) US $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.470B 13.51
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.291B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.868B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.813B 0.00
Indivior (INDV) US $1.652B 7.01
Guardian Pharmacy Services (GRDN) US $1.632B 0.00
Evotec AG (EVO) DE $1.523B 0.00
ARS Pharmaceuticals (SPRY) US $1.420B 180.75
Ocular Therapeutix (OCUL) US $1.402B 0.00
Dyne Therapeutics (DYN) US $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.122B 45.61
Enliven Therapeutics (ELVN) US $1.006B 0.00
Ardelyx (ARDX) US $0.984B 0.00
Harrow (HROW) US $0.948B 0.00
Collegium Pharmaceutical (COLL) US $0.888B 4.72
Avadel Pharmaceuticals (AVDL) IE $0.840B 0.00
Xencor (XNCR) US $0.801B 0.00
AleAnna (ANNA) US $0.758B 0.00
Xeris Biopharma Holdings (XERS) US $0.737B 0.00
Cronos Group (CRON) CA $0.709B 0.00
KalVista Pharmaceuticals (KALV) US $0.674B 0.00
Organogenesis (ORGO) US $0.670B 0.00
Akebia Therapeutics (AKBA) US $0.641B 0.00
Bioventus (BVS) US $0.601B 15.62
Savara (SVRA) US $0.587B 0.00
USANA Health Sciences (USNA) US $0.555B 11.92
Relay Therapeutics (RLAY) US $0.554B 0.00
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.474B 0.00
Verve Therapeutics (VERV) US $0.463B 0.00
Elite Pharmaceuticals (ELTP) US $0.453B 0.00
Altimmune (ALT) US $0.444B 0.00
Zevra Therapeutics (ZVRA) US $0.437B 0.00
Tourmaline Bio (TRML) US $0.419B 0.00
CytoDyn (CYDY) US $0.405B 0.00
Siga Technologies (SIGA) US $0.402B 6.87
Oruka Therapeutics (ORKA) US $0.401B 0.00
Heron Therapeutics (HRTX) US $0.352B 0.00
Rigel Pharmaceuticals (RIGL) US $0.346B 20.60
Aquestive Therapeutics (AQST) US $0.298B 0.00
Avita Medical (RCEL) US $0.244B 0.00
Wellgistics Health (WGRX) US $0.232B 0.00
ProKidney (PROK) US $0.231B 0.00
Nature's Sunshine Products (NATR) US $0.231B 27.15
Esperion Therapeutics (ESPR) US $0.216B 27.25
OmniAb (OABI) US $0.214B 0.00
Korro Bio (KRRO) US $0.197B 0.00
Larimar Therapeutics (LRMR) US $0.190B 0.00
MediWound (MDWD) IL $0.186B 0.00
4D Molecular Therapeutics (FDMT) US $0.174B 0.00
Aldeyra Therapeutics (ALDX) US $0.168B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Journey Medical (DERM) US $0.162B 0.00
Nanobiotix S.A (NBTX) FR $0.157B 0.00
Profound Medical (PROF) CA $0.157B 0.00
Aclaris Therapeutics (ACRS) US $0.156B 0.00
Lexeo Therapeutics (LXEO) US $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.151B 46.61
Procaps Group, S.A (PROCF) LU $0.141B 0.00
Nektar Therapeutics (NKTR) US $0.140B 0.00
Protara Therapeutics (TARA) US $0.138B 0.00
Lyell Immunopharma (LYEL) US $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.129B 0.00
Enanta Pharmaceuticals (ENTA) US $0.127B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
VAXART, INC (VXRT) US $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.095B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.094B 0.00
Achieve Life Sciences (ACHV) CA $0.089B 0.00
Galectin Therapeutics (GALT) US $0.088B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Dominari Holdings (DOMH) US $0.083B 0.00
Champions Oncology (CSBR) US $0.080B 13.11
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Pyxis Oncology (PYXS) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Fractyl Health (GUTS) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.077B 0.00
ESSA Pharma (EPIX) CA $0.077B 0.00
Nutriband (NTRB) US $0.071B 0.00
Inotiv (NOTV) US $0.068B 0.00
Karyopharm Therapeutics (KPTI) US $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.063B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Gain Therapeutics (GANX) US $0.061B 0.00
Metagenomi (MGX) US $0.060B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
ElectroCore (ECOR) US $0.049B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
Mural Oncology (MURA) IE $0.046B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
SCYNEXIS (SCYX) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
Prelude Therapeutics (PRLD) US $0.039B 0.00
Rafael Holdings (RFL) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.035B 0.00
FibroGen (FGEN) US $0.034B 0.00
Surrozen (SRZN) US $0.033B 0.00
PolyPid (PYPD) IL $0.028B 0.00
Tempest Therapeutics (TPST) US $0.026B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
BioVie (BIVI) US $0.022B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.021B 0.00
Mannatech (MTEX) US $0.020B 7.75
DURECT (DRRX) US $0.019B 0.00
Natural Alternatives (NAII) US $0.018B 0.00
Lipocine (LPCN) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
Cosmos Health (COSM) US $0.012B 0.00
Relmada Therapeutics (RLMD) US $0.012B 0.00
TransCode Therapeutics (RNAZ) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.95
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Carisma Therapeutics (CARM) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.19
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Jaguar Animal Health (JAGX) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Ainos (AIMD) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Citius Pharmaceuticals (CTXR) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00